Last 12 months
Inside the activity.
0 purchase rows · 0 sale rows
Disclosed non-derivative P/S rows, by transaction month. Includes amendments and private transactions.Monthly counts
| Month | Purchases | Sales |
|---|---|---|
| Nov 2025 | 0 | 0 |
| Dec 2025 | 0 | 0 |
| Jan 2026 | 0 | 0 |
| Feb 2026 | 0 | 0 |
| Mar 2026 | 0 | 0 |
| Apr 2026 | 0 | 0 |
| May 2026 | 0 | 0 |
| Jun 2026 | 0 | 0 |
| Jul 2026 | 0 | 0 |
| Aug 2026 | 0 | 0 |
| Sep 2026 | 0 | 0 |
| Oct 2026 | 0 | 0 |
Latest available
Insider transactions
Purchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Owner / reported role | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| May 15, 2023 Filed May 16, 2023 20:57 UTC |
Zoth Lota S.Director
|
GrantRestricted Stock Unit · Derivative | 26,000 | $0.00 | $0.00 |
DisclosureSEC source: 0001055726-23-000039 · wk-form4_1684270611.xml · derivative · entry 4 Zoth Lota S. · CIK 0001278219 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 26,000 Underlying: Common Stock · 26,000 shares Expires not disclosed F4 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of common stock. These restricted stock units will vest 100% on May 15, 2024. F2 · shares: This grant was made under the 2016 Omnibus Incentive Plan pursuant to the issuer's non-employee director compensation policy. F4 · derivative.exercise_date: Each restricted stock unit represents a contingent right to receive one share of common stock. These restricted stock units will vest 100% on May 15, 2024. F4 · derivative.expiration_date: Each restricted stock unit represents a contingent right to receive one share of common stock. These restricted stock units will vest 100% on May 15, 2024. Read SEC document |
| May 15, 2023 Filed May 16, 2023 20:57 UTC |
Zoth Lota S.Director
|
GrantCommon Stock Options · Derivative | 35,000 | $0.00 Strike: $0.77 | $0.00 |
DisclosureSEC source: 0001055726-23-000039 · wk-form4_1684270611.xml · derivative · entry 3 Zoth Lota S. · CIK 0001278219 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 35,000 Underlying: Common Stock · 35,000 shares Expires 2033-05-15 F2 · shares: This grant was made under the 2016 Omnibus Incentive Plan pursuant to the issuer's non-employee director compensation policy. F3 · derivative.exercise_date: Options to vest 100% on May 15, 2024. Read SEC document |
| May 15, 2023 Filed May 16, 2023 20:56 UTC |
YARNO WENDY LDirector
|
GrantRestricted Stock Unit · Derivative | 26,000 | $0.00 | $0.00 |
DisclosureSEC source: 0001055726-23-000038 · wk-form4_1684270551.xml · derivative · entry 4 YARNO WENDY L · CIK 0001181186 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 26,000 Underlying: Common Stock · 26,000 shares Expires not disclosed F4 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of common stock. These restricted stock units will vest 100% on May 15, 2024. F2 · shares: This grant was made under the 2016 Omnibus Incentive Plan pursuant to the issuer's non-employee director compensation policy. F4 · derivative.exercise_date: Each restricted stock unit represents a contingent right to receive one share of common stock. These restricted stock units will vest 100% on May 15, 2024. F4 · derivative.expiration_date: Each restricted stock unit represents a contingent right to receive one share of common stock. These restricted stock units will vest 100% on May 15, 2024. Read SEC document |
| May 15, 2023 Filed May 16, 2023 20:56 UTC |
YARNO WENDY LDirector
|
GrantCommon Stock Options · Derivative | 35,000 | $0.00 Strike: $0.77 | $0.00 |
DisclosureSEC source: 0001055726-23-000038 · wk-form4_1684270551.xml · derivative · entry 3 YARNO WENDY L · CIK 0001181186 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 35,000 Underlying: Common Stock · 35,000 shares Expires 2033-05-15 F2 · shares: This grant was made under the 2016 Omnibus Incentive Plan pursuant to the issuer's non-employee director compensation policy. F3 · derivative.exercise_date: Options to vest 100% on May 15, 2024. Read SEC document |
| May 15, 2023 Filed May 16, 2023 20:54 UTC |
Weiner David B.Director
|
GrantRestricted Stock Unit · Derivative | 26,000 | $0.00 | $0.00 |
DisclosureSEC source: 0001055726-23-000037 · wk-form4_1684270484.xml · derivative · entry 4 Weiner David B. · CIK 0001669080 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 26,000 Underlying: Common Stock · 26,000 shares Expires not disclosed F4 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of common stock. The restricted stock units will vest 100% on May 15, 2024. F2 · shares: This grant was made under the 2016 Omnibus Incentive Plan pursuant to the issuer's non-employee director compensation policy. F4 · derivative.exercise_date: Each restricted stock unit represents a contingent right to receive one share of common stock. The restricted stock units will vest 100% on May 15, 2024. F4 · derivative.expiration_date: Each restricted stock unit represents a contingent right to receive one share of common stock. The restricted stock units will vest 100% on May 15, 2024. Read SEC document |
| May 15, 2023 Filed May 16, 2023 20:54 UTC |
Weiner David B.Director
|
GrantCommon Stock Options · Derivative | 35,000 | $0.00 Strike: $0.77 | $0.00 |
DisclosureSEC source: 0001055726-23-000037 · wk-form4_1684270484.xml · derivative · entry 3 Weiner David B. · CIK 0001669080 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 35,000 Underlying: Common Stock · 35,000 shares Expires 2033-05-15 F2 · shares: This grant was made under the 2016 Omnibus Incentive Plan pursuant to the issuer's non-employee director compensation policy. F3 · derivative.exercise_date: Options to vest 100% on May 15, 2024. Read SEC document |
| May 15, 2023 Filed May 16, 2023 20:52 UTC |
BENITO SIMON XDirector
|
GrantRestricted Stock Unit · Derivative | 26,000 | $0.00 | $0.00 |
DisclosureSEC source: 0001055726-23-000035 · wk-form4_1684270316.xml · derivative · entry 4 BENITO SIMON X · CIK 0001273306 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 26,000 Underlying: Common Stock · 26,000 shares Expires not disclosed F4 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of common stock. These restricted stock units will vest 100% on May 15, 2024. F2 · shares: This grant was made under the 2016 Omnibus Incentive Plan pursuant to the issuer's non-employee director compensation policy. F4 · derivative.exercise_date: Each restricted stock unit represents a contingent right to receive one share of common stock. These restricted stock units will vest 100% on May 15, 2024. F4 · derivative.expiration_date: Each restricted stock unit represents a contingent right to receive one share of common stock. These restricted stock units will vest 100% on May 15, 2024. Read SEC document |
| May 15, 2023 Filed May 16, 2023 20:52 UTC |
BENITO SIMON XDirector
|
GrantCommon Stock Options · Derivative | 35,000 | $0.00 Strike: $0.77 | $0.00 |
DisclosureSEC source: 0001055726-23-000035 · wk-form4_1684270316.xml · derivative · entry 3 BENITO SIMON X · CIK 0001273306 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 35,000 Underlying: Common Stock · 35,000 shares Expires 2033-05-15 F2 · shares: This grant was made under the 2016 Omnibus Incentive Plan pursuant to the issuer's non-employee director compensation policy. F3 · derivative.exercise_date: Options to vest 100% on May 15, 2024. Read SEC document |
| May 15, 2023 Filed May 16, 2023 20:53 UTC |
Shepard JayDirector
|
GrantRestricted Stock Unit · Derivative | 26,000 | $0.00 | $0.00 |
DisclosureSEC source: 0001055726-23-000036 · wk-form4_1684270397.xml · derivative · entry 4 Shepard Jay · CIK 0001587788 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 26,000 Underlying: Common Stock · 26,000 shares Expires not disclosed F4 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of common stock. These restricted stock units will vest 100% on May 15, 2024. F2 · shares: This grant was made under the 2016 Omnibus Incentive Plan pursuant to the issuer's non-employee director compensation policy. F4 · derivative.exercise_date: Each restricted stock unit represents a contingent right to receive one share of common stock. These restricted stock units will vest 100% on May 15, 2024. F4 · derivative.expiration_date: Each restricted stock unit represents a contingent right to receive one share of common stock. These restricted stock units will vest 100% on May 15, 2024. Read SEC document |
| May 15, 2023 Filed May 16, 2023 20:53 UTC |
Shepard JayDirector
|
GrantCommon Stock Options · Derivative | 35,000 | $0.00 Strike: $0.77 | $0.00 |
DisclosureSEC source: 0001055726-23-000036 · wk-form4_1684270397.xml · derivative · entry 3 Shepard Jay · CIK 0001587788 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 35,000 Underlying: Common Stock · 35,000 shares Expires 2033-05-15 F2 · shares: This grant was made under the 2016 Omnibus Incentive Plan pursuant to the issuer's non-employee director compensation policy. F3 · derivative.exercise_date: Options to vest 100% on May 15, 2024. Read SEC document |
| May 15, 2023 Filed May 16, 2023 20:50 UTC |
Miller Ann CalbyDirector
|
GrantRestricted Stock Unit · Derivative | 26,000 | $0.00 | $0.00 |
DisclosureSEC source: 0001055726-23-000034 · wk-form4_1684270239.xml · derivative · entry 4 Miller Ann Calby · CIK 0001771423 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 26,000 Underlying: Common Stock · 26,000 shares Expires not disclosed F4 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of common stock. These restricted stock units will vest 100% on May 15, 2024. F2 · shares: This grant was made under the 2016 Omnibus Incentive Plan pursuant to the issuer's non-employee director compensation policy. F4 · derivative.exercise_date: Each restricted stock unit represents a contingent right to receive one share of common stock. These restricted stock units will vest 100% on May 15, 2024. F4 · derivative.expiration_date: Each restricted stock unit represents a contingent right to receive one share of common stock. These restricted stock units will vest 100% on May 15, 2024. Read SEC document |
| May 15, 2023 Filed May 16, 2023 20:50 UTC |
Miller Ann CalbyDirector
|
GrantCommon Stock Options · Derivative | 35,000 | $0.00 Strike: $0.77 | $0.00 |
DisclosureSEC source: 0001055726-23-000034 · wk-form4_1684270239.xml · derivative · entry 3 Miller Ann Calby · CIK 0001771423 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 35,000 Underlying: Common Stock · 35,000 shares Expires 2033-05-15 F2 · shares: This grant was made under the 2016 Omnibus Incentive Plan pursuant to the issuer's non-employee director compensation policy. F3 · derivative.exercise_date: Options to vest 100% on May 15, 2024. Read SEC document |
| May 15, 2023 Filed May 16, 2023 20:48 UTC |
DANSEY ROGER DDirector
|
GrantRestricted Stock Unit · Derivative | 26,000 | $0.00 | $0.00 |
DisclosureSEC source: 0001055726-23-000033 · wk-form4_1684270114.xml · derivative · entry 5 DANSEY ROGER D · CIK 0001741836 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 26,000 Underlying: Common Stock · 26,000 shares Expires not disclosed F5 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of common stock. The restricted stock units will vest 100% on May 15, 2024. F3 · shares: This grant was made under the 2016 Omnibus Incentive Plan pursuant to the issuer's non-employee director compensation policy. F5 · derivative.exercise_date: Each restricted stock unit represents a contingent right to receive one share of common stock. The restricted stock units will vest 100% on May 15, 2024. F5 · derivative.expiration_date: Each restricted stock unit represents a contingent right to receive one share of common stock. The restricted stock units will vest 100% on May 15, 2024. Read SEC document |
| May 15, 2023 Filed May 16, 2023 20:48 UTC |
DANSEY ROGER DDirector
|
GrantCommon Stock Options · Derivative | 35,000 | $0.00 Strike: $0.77 | $0.00 |
DisclosureSEC source: 0001055726-23-000033 · wk-form4_1684270114.xml · derivative · entry 4 DANSEY ROGER D · CIK 0001741836 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 35,000 Underlying: Common Stock · 35,000 shares Expires 2033-05-15 F3 · shares: This grant was made under the 2016 Omnibus Incentive Plan pursuant to the issuer's non-employee director compensation policy. F4 · derivative.exercise_date: Options to vest 100% on May 15, 2024. Read SEC document |
| May 15, 2023 Filed May 17, 2023 20:11 UTC |
Humeau LaurentChief Scientific Officer
|
GrantRestricted Stock Unit · Derivative | 171,756 | $0.00 | $0.00 |
DisclosureSEC source: 0001055726-23-000042 · wk-form4_1684354280.xml · derivative · entry 1 Humeau Laurent · CIK 0001770390 · Chief Scientific Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 171,756 Underlying: Common Stock · 171,756 shares Expires not disclosed F1 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of common stock. The vesting schedule for the 171,756 restricted stock units is as follows: 57,252 shares will vest on May 15, 2024; 57,252 shares will vest on May 15, 2025; and 57,252 shares will vest on May 15, 2026. Vested restricted stock units can be settled in shares of common stock, cash or a combination of both. F2 · shares: This grant was made under the 2016 Omnibus Incentive Plan. F1 · derivative.exercise_date: Each restricted stock unit represents a contingent right to receive one share of common stock. The vesting schedule for the 171,756 restricted stock units is as follows: 57,252 shares will vest on May 15, 2024; 57,252 shares will vest on May 15, 2025; and 57,252 shares will vest on May 15, 2026. Vested restricted stock units can be settled in shares of common stock, cash or a combination of both. F1 · derivative.expiration_date: Each restricted stock unit represents a contingent right to receive one share of common stock. The vesting schedule for the 171,756 restricted stock units is as follows: 57,252 shares will vest on May 15, 2024; 57,252 shares will vest on May 15, 2025; and 57,252 shares will vest on May 15, 2026. Vested restricted stock units can be settled in shares of common stock, cash or a combination of both. Read SEC document |
| May 15, 2023 Filed May 17, 2023 20:12 UTC |
Sumner Michael JohnChief Medical Officer
|
GrantRestricted Stock Unit · Derivative | 85,878 | $0.00 | $0.00 |
DisclosureSEC source: 0001055726-23-000043 · wk-form4_1684354347.xml · derivative · entry 1 Sumner Michael John · CIK 0001936799 · Chief Medical Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 85,878 Underlying: Common Stock · 85,878 shares Expires not disclosed F1 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of common stock. The vesting schedule for the 85,878 restricted stock units is as follows: 28,626 shares will vest on May 15, 2024; 28,626 shares will vest on May 15, 2025; and 28,626 shares will vest on May 15, 2026. Vested restricted stock units can be settled in shares of common stock, cash or a combination of both. F2 · shares: This grant was made under the 2016 Omnibus Incentive Plan. F1 · derivative.exercise_date: Each restricted stock unit represents a contingent right to receive one share of common stock. The vesting schedule for the 85,878 restricted stock units is as follows: 28,626 shares will vest on May 15, 2024; 28,626 shares will vest on May 15, 2025; and 28,626 shares will vest on May 15, 2026. Vested restricted stock units can be settled in shares of common stock, cash or a combination of both. F1 · derivative.expiration_date: Each restricted stock unit represents a contingent right to receive one share of common stock. The vesting schedule for the 85,878 restricted stock units is as follows: 28,626 shares will vest on May 15, 2024; 28,626 shares will vest on May 15, 2025; and 28,626 shares will vest on May 15, 2026. Vested restricted stock units can be settled in shares of common stock, cash or a combination of both. Read SEC document |
| May 15, 2023 Filed May 17, 2023 20:10 UTC |
KIES PETERCFO
|
GrantRestricted Stock Unit · Derivative | 171,756 | $0.00 | $0.00 |
DisclosureSEC source: 0001055726-23-000041 · wk-form4_1684354196.xml · derivative · entry 1 KIES PETER · CIK 0001259780 · CFO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 171,756 Underlying: Common Stock · 171,756 shares Expires not disclosed F1 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of common stock. The vesting schedule for the 171,756 restricted stock units is as follows: 57,252 shares will vest on May 15, 2024; 57,252 shares will vest on May 15, 2025; and 57,252 shares will vest on May 15, 2026. Vested restricted stock units can be settled in shares of common stock, cash or a combination of both. F2 · shares: This grant was made under the 2016 Omnibus Incentive Plan. F1 · derivative.exercise_date: Each restricted stock unit represents a contingent right to receive one share of common stock. The vesting schedule for the 171,756 restricted stock units is as follows: 57,252 shares will vest on May 15, 2024; 57,252 shares will vest on May 15, 2025; and 57,252 shares will vest on May 15, 2026. Vested restricted stock units can be settled in shares of common stock, cash or a combination of both. F1 · derivative.expiration_date: Each restricted stock unit represents a contingent right to receive one share of common stock. The vesting schedule for the 171,756 restricted stock units is as follows: 57,252 shares will vest on May 15, 2024; 57,252 shares will vest on May 15, 2025; and 57,252 shares will vest on May 15, 2026. Vested restricted stock units can be settled in shares of common stock, cash or a combination of both. Read SEC document |
| May 15, 2023 Filed May 17, 2023 20:08 UTC |
Shea Jacqueline ElizabethDirector · Chief Executive Officer
|
GrantRestricted Stock Unit · Derivative | 638,800 | $0.00 | $0.00 |
DisclosureSEC source: 0001055726-23-000040 · wk-form4_1684354107.xml · derivative · entry 1 Shea Jacqueline Elizabeth · CIK 0001771498 · Director · Chief Executive Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 638,800 Underlying: Common Stock · 638,800 shares Expires not disclosed F1 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of common stock. The vesting schedule for the 638,800 restricted stock units is as follows: 212,934 shares will vest on May 15, 2024; 212,933 shares will vest on May 15, 2025; and 212,933 shares will vest on May 15, 2026. Vested restricted stock units can be settled in shares of common stock, cash or a combination of both. F2 · shares: This grant was made under the 2016 Omnibus Incentive Plan. F1 · derivative.exercise_date: Each restricted stock unit represents a contingent right to receive one share of common stock. The vesting schedule for the 638,800 restricted stock units is as follows: 212,934 shares will vest on May 15, 2024; 212,933 shares will vest on May 15, 2025; and 212,933 shares will vest on May 15, 2026. Vested restricted stock units can be settled in shares of common stock, cash or a combination of both. F1 · derivative.expiration_date: Each restricted stock unit represents a contingent right to receive one share of common stock. The vesting schedule for the 638,800 restricted stock units is as follows: 212,934 shares will vest on May 15, 2024; 212,933 shares will vest on May 15, 2025; and 212,933 shares will vest on May 15, 2026. Vested restricted stock units can be settled in shares of common stock, cash or a combination of both. Read SEC document |
| May 13, 2023 Filed May 16, 2023 20:48 UTC |
DANSEY ROGER DDirector
|
Exercise / conversionRestricted Stock Unit · Derivative | 12,000 | $0.00 | $0.00 |
DisclosureSEC source: 0001055726-23-000033 · wk-form4_1684270114.xml · derivative · entry 3 DANSEY ROGER D · CIK 0001741836 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 12,000 Underlying: Common Stock · 12,000 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of common stock. The vesting schedule for the 36,000 restricted stock units is as follows: 12,000 shares vested on May 13, 2022; 12,000 shares vested on May 13, 2023; 12,000 shares will vest on May 13, 2024. Vested restricted stock units can be settled in shares of common stock, cash or a combination of both. F1 · derivative.exercise_date: Each restricted stock unit represents a contingent right to receive one share of common stock. The vesting schedule for the 36,000 restricted stock units is as follows: 12,000 shares vested on May 13, 2022; 12,000 shares vested on May 13, 2023; 12,000 shares will vest on May 13, 2024. Vested restricted stock units can be settled in shares of common stock, cash or a combination of both. F1 · derivative.expiration_date: Each restricted stock unit represents a contingent right to receive one share of common stock. The vesting schedule for the 36,000 restricted stock units is as follows: 12,000 shares vested on May 13, 2022; 12,000 shares vested on May 13, 2023; 12,000 shares will vest on May 13, 2024. Vested restricted stock units can be settled in shares of common stock, cash or a combination of both. Read SEC document |
| May 13, 2023 Filed May 16, 2023 20:48 UTC |
DANSEY ROGER DDirector
|
Exercise / conversionCommon Stock | 12,000 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001055726-23-000033 · wk-form4_1684270114.xml · nonDerivative · entry 1 DANSEY ROGER D · CIK 0001741836 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 24,000 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · price: Each restricted stock unit represents a contingent right to receive one share of common stock. The vesting schedule for the 36,000 restricted stock units is as follows: 12,000 shares vested on May 13, 2022; 12,000 shares vested on May 13, 2023; 12,000 shares will vest on May 13, 2024. Vested restricted stock units can be settled in shares of common stock, cash or a combination of both. Read SEC document |
| May 10, 2023 Filed May 12, 2023 20:12 UTC |
Shea Jacqueline ElizabethDirector · Chief Executive Officer
|
Exercise / conversionRestricted Stock Unit · Derivative | 66,000 | $0.00 | $0.00 |
DisclosureSEC source: 0001055726-23-000032 · wk-form4_1683922339.xml · derivative · entry 3 Shea Jacqueline Elizabeth · CIK 0001771498 · Director · Chief Executive Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 132,000 Underlying: Common Stock · 66,000 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of common stock. The vesting schedule for the 198,000 restricted stock units is as follows: 66,000 shares vested on May 10, 2023; 66,000 shares will vest on May 10, 2024; 66,000 shares will vest on May 10, 2025. Vested restricted stock units can be settled in shares of common stock, cash or a combination of both. F1 · derivative.exercise_date: Each restricted stock unit represents a contingent right to receive one share of common stock. The vesting schedule for the 198,000 restricted stock units is as follows: 66,000 shares vested on May 10, 2023; 66,000 shares will vest on May 10, 2024; 66,000 shares will vest on May 10, 2025. Vested restricted stock units can be settled in shares of common stock, cash or a combination of both. F1 · derivative.expiration_date: Each restricted stock unit represents a contingent right to receive one share of common stock. The vesting schedule for the 198,000 restricted stock units is as follows: 66,000 shares vested on May 10, 2023; 66,000 shares will vest on May 10, 2024; 66,000 shares will vest on May 10, 2025. Vested restricted stock units can be settled in shares of common stock, cash or a combination of both. Read SEC document |
| May 10, 2023 Filed May 12, 2023 20:12 UTC |
Shea Jacqueline ElizabethDirector · Chief Executive Officer
|
Tax withholdingCommon Stock | 28,704 | $0.81 | $23,250.24 |
DisclosureSEC source: 0001055726-23-000032 · wk-form4_1683922339.xml · nonDerivative · entry 2 Shea Jacqueline Elizabeth · CIK 0001771498 · Director · Chief Executive Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 198,113 F2 · kind: The transaction reported represents the withholding of shares by the issuer to satisfy the reporting person's tax withholding obligations in connection with the vesting and settlement of the restricted stock unit award reported in footnote (1) herein. Read SEC document |
| May 10, 2023 Filed May 12, 2023 20:12 UTC |
Shea Jacqueline ElizabethDirector · Chief Executive Officer
|
Exercise / conversionCommon Stock | 66,000 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001055726-23-000032 · wk-form4_1683922339.xml · nonDerivative · entry 1 Shea Jacqueline Elizabeth · CIK 0001771498 · Director · Chief Executive Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 226,817 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · price: Each restricted stock unit represents a contingent right to receive one share of common stock. The vesting schedule for the 198,000 restricted stock units is as follows: 66,000 shares vested on May 10, 2023; 66,000 shares will vest on May 10, 2024; 66,000 shares will vest on May 10, 2025. Vested restricted stock units can be settled in shares of common stock, cash or a combination of both. Read SEC document |
| March 13, 2023 Filed Mar 13, 2023 21:10 UTC |
Weiner David B.Director
|
SaleCommon Stock | 5,833 | $1.15 | $6,707.95 |
DisclosureSEC source: 0001055726-23-000014 · wf-form4_167874179632291.xml · nonDerivative · entry 2 Weiner David B. · CIK 0001669080 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 910,124 F2 · kind: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on April 13, 2022. Read SEC document |
| March 11, 2023 Filed Mar 13, 2023 21:09 UTC |
Humeau LaurentChief Scientific Officer
|
Exercise / conversionRestricted Stock Unit · Derivative | 59,737 | $0.00 | $0.00 |
DisclosureSEC source: 0001055726-23-000013 · wf-form4_167874172348787.xml · derivative · entry 3 Humeau Laurent · CIK 0001770390 · Chief Scientific Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 59,737 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of common stock. On March 11, 2020, the reporting person was granted 179,211 restricted stock units, vesting as follows: 59,737 shares vested on March 11, 2021; 59,737 shares vested on March 11, 2022; and 59,737 shares vested on March 11, 2023. Vested restricted stock units can be settled in shares of common stock, cash or a combination of both. F1 · derivative.exercise_date: Each restricted stock unit represents a contingent right to receive one share of common stock. On March 11, 2020, the reporting person was granted 179,211 restricted stock units, vesting as follows: 59,737 shares vested on March 11, 2021; 59,737 shares vested on March 11, 2022; and 59,737 shares vested on March 11, 2023. Vested restricted stock units can be settled in shares of common stock, cash or a combination of both. F1 · derivative.expiration_date: Each restricted stock unit represents a contingent right to receive one share of common stock. On March 11, 2020, the reporting person was granted 179,211 restricted stock units, vesting as follows: 59,737 shares vested on March 11, 2021; 59,737 shares vested on March 11, 2022; and 59,737 shares vested on March 11, 2023. Vested restricted stock units can be settled in shares of common stock, cash or a combination of both. Read SEC document |
| March 11, 2023 Filed Mar 13, 2023 21:09 UTC |
Humeau LaurentChief Scientific Officer
|
Tax withholdingCommon Stock | 20,658 | $1.13 | $23,343.54 |
DisclosureSEC source: 0001055726-23-000013 · wf-form4_167874172348787.xml · nonDerivative · entry 2 Humeau Laurent · CIK 0001770390 · Chief Scientific Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 214,637 F2 · kind: The transaction reported represents the withholding of shares by the issuer to satisfy the reporting person's tax withholding obligations in connection with the vesting and settlement of the restricted stock unit award reported in footnote (1) herein. Read SEC document |
| March 11, 2023 Filed Mar 13, 2023 21:09 UTC |
Humeau LaurentChief Scientific Officer
|
Exercise / conversionCommon Stock | 59,737 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001055726-23-000013 · wf-form4_167874172348787.xml · nonDerivative · entry 1 Humeau Laurent · CIK 0001770390 · Chief Scientific Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 235,295 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · price: Each restricted stock unit represents a contingent right to receive one share of common stock. On March 11, 2020, the reporting person was granted 179,211 restricted stock units, vesting as follows: 59,737 shares vested on March 11, 2021; 59,737 shares vested on March 11, 2022; and 59,737 shares vested on March 11, 2023. Vested restricted stock units can be settled in shares of common stock, cash or a combination of both. Read SEC document |
| March 11, 2023 Filed Mar 13, 2023 21:10 UTC |
Weiner David B.Director
|
Exercise / conversionRestricted Stock Unit · Derivative | 11,666 | $0.00 | $0.00 |
DisclosureSEC source: 0001055726-23-000014 · wf-form4_167874179632291.xml · derivative · entry 3 Weiner David B. · CIK 0001669080 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 11,666 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of common stock. On March 11, 2020, the reporting person was granted 35,000 restricted stock units, vesting as follows: 11,667 shares vested on March 11, 2021; 11,667 shares vested on March 11, 2022; and 11,666 shares vested on March 11, 2023. Vested restricted stock units can be settled in shares of common stock, cash or a combination of both. F1 · derivative.exercise_date: Each restricted stock unit represents a contingent right to receive one share of common stock. On March 11, 2020, the reporting person was granted 35,000 restricted stock units, vesting as follows: 11,667 shares vested on March 11, 2021; 11,667 shares vested on March 11, 2022; and 11,666 shares vested on March 11, 2023. Vested restricted stock units can be settled in shares of common stock, cash or a combination of both. F1 · derivative.expiration_date: Each restricted stock unit represents a contingent right to receive one share of common stock. On March 11, 2020, the reporting person was granted 35,000 restricted stock units, vesting as follows: 11,667 shares vested on March 11, 2021; 11,667 shares vested on March 11, 2022; and 11,666 shares vested on March 11, 2023. Vested restricted stock units can be settled in shares of common stock, cash or a combination of both. Read SEC document |
| March 11, 2023 Filed Mar 13, 2023 21:10 UTC |
Weiner David B.Director
|
Exercise / conversionCommon Stock | 11,666 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001055726-23-000014 · wf-form4_167874179632291.xml · nonDerivative · entry 1 Weiner David B. · CIK 0001669080 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 915,957 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · price: Each restricted stock unit represents a contingent right to receive one share of common stock. On March 11, 2020, the reporting person was granted 35,000 restricted stock units, vesting as follows: 11,667 shares vested on March 11, 2021; 11,667 shares vested on March 11, 2022; and 11,666 shares vested on March 11, 2023. Vested restricted stock units can be settled in shares of common stock, cash or a combination of both. Read SEC document |
| March 11, 2023 Filed Mar 13, 2023 21:07 UTC |
Shea Jacqueline ElizabethDirector · Chief Executive Officer
|
Exercise / conversionRestricted Stock Unit · Derivative | 59,737 | $0.00 | $0.00 |
DisclosureSEC source: 0001055726-23-000012 · wf-form4_167874165226829.xml · derivative · entry 3 Shea Jacqueline Elizabeth · CIK 0001771498 · Director · Chief Executive Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 59,737 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of common stock. On March 11, 2020, the reporting person was granted 179,211 restricted stock units, vesting as follows: 59,737 shares vested on March 11, 2021; 59,737 shares vested on March 11, 2022; and 59,737 shares vested on March 11, 2023. Vested restricted stock units can be settled in shares of common stock, cash or a combination of both. F1 · derivative.exercise_date: Each restricted stock unit represents a contingent right to receive one share of common stock. On March 11, 2020, the reporting person was granted 179,211 restricted stock units, vesting as follows: 59,737 shares vested on March 11, 2021; 59,737 shares vested on March 11, 2022; and 59,737 shares vested on March 11, 2023. Vested restricted stock units can be settled in shares of common stock, cash or a combination of both. F1 · derivative.expiration_date: Each restricted stock unit represents a contingent right to receive one share of common stock. On March 11, 2020, the reporting person was granted 179,211 restricted stock units, vesting as follows: 59,737 shares vested on March 11, 2021; 59,737 shares vested on March 11, 2022; and 59,737 shares vested on March 11, 2023. Vested restricted stock units can be settled in shares of common stock, cash or a combination of both. Read SEC document |
| March 11, 2023 Filed Mar 13, 2023 21:07 UTC |
Shea Jacqueline ElizabethDirector · Chief Executive Officer
|
Tax withholdingCommon Stock | 25,980 | $1.13 | $29,357.40 |
DisclosureSEC source: 0001055726-23-000012 · wf-form4_167874165226829.xml · nonDerivative · entry 2 Shea Jacqueline Elizabeth · CIK 0001771498 · Director · Chief Executive Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 160,817 F2 · kind: The transaction reported represents the withholding of shares by the issuer to satisfy the reporting person's tax withholding obligations in connection with the vesting and settlement of the restricted stock unit award reported in footnote (1) herein. Read SEC document |
| March 11, 2023 Filed Mar 13, 2023 21:07 UTC |
Shea Jacqueline ElizabethDirector · Chief Executive Officer
|
Exercise / conversionCommon Stock | 59,737 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001055726-23-000012 · wf-form4_167874165226829.xml · nonDerivative · entry 1 Shea Jacqueline Elizabeth · CIK 0001771498 · Director · Chief Executive Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 186,797 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · price: Each restricted stock unit represents a contingent right to receive one share of common stock. On March 11, 2020, the reporting person was granted 179,211 restricted stock units, vesting as follows: 59,737 shares vested on March 11, 2021; 59,737 shares vested on March 11, 2022; and 59,737 shares vested on March 11, 2023. Vested restricted stock units can be settled in shares of common stock, cash or a combination of both. Read SEC document |
| March 11, 2023 Filed Mar 13, 2023 21:06 UTC |
KIES PETERCFO
|
Exercise / conversionRestricted Stock Unit · Derivative | 59,737 | $0.00 | $0.00 |
DisclosureSEC source: 0001055726-23-000011 · wf-form4_167874156199535.xml · derivative · entry 4 KIES PETER · CIK 0001259780 · CFO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 59,737 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of common stock. On March 11, 2020, the reporting person was granted 179,211 restricted stock units, vesting as follows: 59,737 shares vested on March 11, 2021; 59,737 shares vested on March 11, 2022; and 59,737 shares vested on March 11, 2023. Vested restricted stock units can be settled in shares of common stock, cash or a combination of both. F1 · derivative.exercise_date: Each restricted stock unit represents a contingent right to receive one share of common stock. On March 11, 2020, the reporting person was granted 179,211 restricted stock units, vesting as follows: 59,737 shares vested on March 11, 2021; 59,737 shares vested on March 11, 2022; and 59,737 shares vested on March 11, 2023. Vested restricted stock units can be settled in shares of common stock, cash or a combination of both. F1 · derivative.expiration_date: Each restricted stock unit represents a contingent right to receive one share of common stock. On March 11, 2020, the reporting person was granted 179,211 restricted stock units, vesting as follows: 59,737 shares vested on March 11, 2021; 59,737 shares vested on March 11, 2022; and 59,737 shares vested on March 11, 2023. Vested restricted stock units can be settled in shares of common stock, cash or a combination of both. Read SEC document |
| March 11, 2023 Filed Mar 13, 2023 21:06 UTC |
KIES PETERCFO
|
Tax withholdingCommon Stock | 31,410 | $1.13 | $35,493.30 |
DisclosureSEC source: 0001055726-23-000011 · wf-form4_167874156199535.xml · nonDerivative · entry 2 KIES PETER · CIK 0001259780 · CFO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 236,999 F2 · kind: The transaction reported represents the withholding of shares by the issuer to satisfy the reporting person's tax withholding obligations in connection with the vesting and settlement of the restricted stock unit award reported in footnote (1) herein. Read SEC document |
| March 11, 2023 Filed Mar 13, 2023 21:06 UTC |
KIES PETERCFO
|
Exercise / conversionCommon Stock | 59,737 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001055726-23-000011 · wf-form4_167874156199535.xml · nonDerivative · entry 1 KIES PETER · CIK 0001259780 · CFO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 268,409 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · price: Each restricted stock unit represents a contingent right to receive one share of common stock. On March 11, 2020, the reporting person was granted 179,211 restricted stock units, vesting as follows: 59,737 shares vested on March 11, 2021; 59,737 shares vested on March 11, 2022; and 59,737 shares vested on March 11, 2023. Vested restricted stock units can be settled in shares of common stock, cash or a combination of both. Read SEC document |
| February 27, 2023 Filed Feb 28, 2023 22:44 UTC |
Shea Jacqueline ElizabethDirector · Chief Executive Officer
|
GrantCommon Stock Option · Derivative | 836,800 | $0.00 Strike: $1.24 | $0.00 |
DisclosureSEC source: 0001055726-23-000007 · wf-form4_167762425136925.xml · derivative · entry 7 Shea Jacqueline Elizabeth · CIK 0001771498 · Director · Chief Executive Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 836,800 Underlying: Common Stock · 836,800 shares Expires 2033-02-27 F5 · derivative.exercise_date: The vesting schedule for the 836,800 options is as follows: 209,200 shares vested on February 27, 2023; 209,200 shares will vest on February 26, 2024; 209,200 shares will vest on February 26, 2025; and 209,200 shares will vest on February 26, 2026. Read SEC document |
| February 27, 2023 Filed Feb 28, 2023 22:43 UTC |
Humeau LaurentChief Scientific Officer
|
GrantCommon Stock Option · Derivative | 225,000 | $0.00 Strike: $1.24 | $0.00 |
DisclosureSEC source: 0001055726-23-000006 · wf-form4_167762417016584.xml · derivative · entry 7 Humeau Laurent · CIK 0001770390 · Chief Scientific Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 225,000 Underlying: Common Stock · 225,000 shares Expires 2033-02-27 F5 · derivative.exercise_date: The vesting schedule for the 225,000 options is as follows: 56,250 shares vested on February 27, 2023; 56,250 shares will vest on February 26, 2024; 56,250 shares will vest on February 26, 2025; and 56,250 shares will vest on February 26, 2026. Read SEC document |
| February 27, 2023 Filed Feb 28, 2023 22:42 UTC |
KIES PETERCFO
|
GrantCommon Stock Option · Derivative | 225,000 | $0.00 Strike: $1.24 | $0.00 |
DisclosureSEC source: 0001055726-23-000005 · wf-form4_167762408938905.xml · derivative · entry 8 KIES PETER · CIK 0001259780 · CFO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 225,000 Underlying: Common Stock · 225,000 shares Expires 2033-02-27 F5 · derivative.exercise_date: The vesting schedule for the 225,000 options is as follows: 56,250 shares vested on February 27, 2023; 56,250 shares will vest on February 26, 2024; 56,250 shares will vest on February 26, 2025; and 56,250 shares will vest on February 26, 2026. Read SEC document |
| February 27, 2023 Filed Feb 28, 2023 22:40 UTC |
Weiner David B.Director
|
GrantRestricted Stock Unit · Derivative | 35,000 | $0.00 | $0.00 |
DisclosureSEC source: 0001055726-23-000004 · wf-form4_167762396172703.xml · derivative · entry 7 Weiner David B. · CIK 0001669080 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 35,000 Underlying: Common Stock · 35,000 shares Expires not disclosed F5 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of common stock. On February 27, 2023, the reporting person was granted 35,000 restricted stock units, vesting as follows: 11,667 shares will vest on February 26, 2024; 11,667 shares will vest on February 26, 2025; and 11,666 shares will vest on February 26, 2026. Vested restricted stock units can be settled in shares of common stock, cash or a combination of both. F5 · derivative.exercise_date: Each restricted stock unit represents a contingent right to receive one share of common stock. On February 27, 2023, the reporting person was granted 35,000 restricted stock units, vesting as follows: 11,667 shares will vest on February 26, 2024; 11,667 shares will vest on February 26, 2025; and 11,666 shares will vest on February 26, 2026. Vested restricted stock units can be settled in shares of common stock, cash or a combination of both. F5 · derivative.expiration_date: Each restricted stock unit represents a contingent right to receive one share of common stock. On February 27, 2023, the reporting person was granted 35,000 restricted stock units, vesting as follows: 11,667 shares will vest on February 26, 2024; 11,667 shares will vest on February 26, 2025; and 11,666 shares will vest on February 26, 2026. Vested restricted stock units can be settled in shares of common stock, cash or a combination of both. Read SEC document |
| February 27, 2023 Filed Feb 28, 2023 22:40 UTC |
Weiner David B.Director
|
GrantCommon Stock Option · Derivative | 60,000 | $0.00 Strike: $1.24 | $0.00 |
DisclosureSEC source: 0001055726-23-000004 · wf-form4_167762396172703.xml · derivative · entry 6 Weiner David B. · CIK 0001669080 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 60,000 Underlying: Common Stock · 60,000 shares Expires 2033-02-27 F4 · derivative.exercise_date: The vesting schedule for the 60,000 options is as follows: 15,000 shares vested on February 27, 2023; 15,000 shares will vest on February 26, 2024; 15,000 shares will vest on February 26, 2025; and 15,000 shares will vest on February 26, 2026. Read SEC document |
| February 27, 2023 Filed Feb 28, 2023 22:40 UTC |
Weiner David B.Director
|
SaleCommon Stock | 11,668 | $1.28 | $14,935.04 |
DisclosureSEC source: 0001055726-23-000004 · wf-form4_167762396172703.xml · nonDerivative · entry 3 Weiner David B. · CIK 0001669080 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 904,291 F3 · kind: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on April 13, 2022. Read SEC document |
| February 27, 2023 Filed Feb 28, 2023 22:38 UTC |
Sumner Michael JohnChief Medical Officer
|
GrantCommon Stock Option · Derivative | 112,500 | $0.00 Strike: $1.24 | $0.00 |
DisclosureSEC source: 0001055726-23-000003 · wf-form4_167762387214994.xml · derivative · entry 1 Sumner Michael John · CIK 0001936799 · Chief Medical Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 112,500 Underlying: Common Stock · 112,500 shares Expires 2033-02-27 F1 · derivative.exercise_date: The vesting schedule for the 112,500 options is as follows: 28,125 shares vested on February 27, 2023; 28,125 shares will vest on February 26, 2024; 28,125 shares will vest on February 26, 2025; and 28,125 shares will vest on February 26, 2026. Read SEC document |
| February 26, 2023 Filed Feb 28, 2023 22:44 UTC |
Shea Jacqueline ElizabethDirector · Chief Executive Officer
|
Exercise / conversionRestricted Stock Unit · Derivative | 70,234 | $0.00 | $0.00 |
DisclosureSEC source: 0001055726-23-000007 · wf-form4_167762425136925.xml · derivative · entry 6 Shea Jacqueline Elizabeth · CIK 0001771498 · Director · Chief Executive Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 140,466 Underlying: Common Stock · 70,234 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F3 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of common stock. On February 26, 2022, the reporting person was granted 210,700 restricted stock units, vesting as follows: 70,234 shares vested on February 26, 2023; 70,233 shares will vest on February 26, 2024; and 70,233 shares will vest on February 26, 2025. Vested restricted stock units can be settled in shares of common stock, cash or a combination of both. F3 · derivative.exercise_date: Each restricted stock unit represents a contingent right to receive one share of common stock. On February 26, 2022, the reporting person was granted 210,700 restricted stock units, vesting as follows: 70,234 shares vested on February 26, 2023; 70,233 shares will vest on February 26, 2024; and 70,233 shares will vest on February 26, 2025. Vested restricted stock units can be settled in shares of common stock, cash or a combination of both. F3 · derivative.expiration_date: Each restricted stock unit represents a contingent right to receive one share of common stock. On February 26, 2022, the reporting person was granted 210,700 restricted stock units, vesting as follows: 70,234 shares vested on February 26, 2023; 70,233 shares will vest on February 26, 2024; and 70,233 shares will vest on February 26, 2025. Vested restricted stock units can be settled in shares of common stock, cash or a combination of both. Read SEC document |
| February 26, 2023 Filed Feb 28, 2023 22:44 UTC |
Shea Jacqueline ElizabethDirector · Chief Executive Officer
|
Exercise / conversionRestricted Stock Unit · Derivative | 22,544 | $0.00 | $0.00 |
DisclosureSEC source: 0001055726-23-000007 · wf-form4_167762425136925.xml · derivative · entry 5 Shea Jacqueline Elizabeth · CIK 0001771498 · Director · Chief Executive Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 22,544 Underlying: Common Stock · 22,544 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of common stock. On February 26, 2021, the reporting person was granted 67,633 restricted stock units, vesting as follows: 22,545 shares vested on February 26, 2022; 22,544 shares vested on February 26, 2023; and 22,544 shares will vest on February 26, 2024. Vested restricted stock units can be settled in shares of common stock, cash or a combination of both. F1 · derivative.exercise_date: Each restricted stock unit represents a contingent right to receive one share of common stock. On February 26, 2021, the reporting person was granted 67,633 restricted stock units, vesting as follows: 22,545 shares vested on February 26, 2022; 22,544 shares vested on February 26, 2023; and 22,544 shares will vest on February 26, 2024. Vested restricted stock units can be settled in shares of common stock, cash or a combination of both. F1 · derivative.expiration_date: Each restricted stock unit represents a contingent right to receive one share of common stock. On February 26, 2021, the reporting person was granted 67,633 restricted stock units, vesting as follows: 22,545 shares vested on February 26, 2022; 22,544 shares vested on February 26, 2023; and 22,544 shares will vest on February 26, 2024. Vested restricted stock units can be settled in shares of common stock, cash or a combination of both. Read SEC document |
| February 26, 2023 Filed Feb 28, 2023 22:44 UTC |
Shea Jacqueline ElizabethDirector · Chief Executive Officer
|
Tax withholdingCommon Stock | 32,485 | $1.28 | $41,580.80 |
DisclosureSEC source: 0001055726-23-000007 · wf-form4_167762425136925.xml · nonDerivative · entry 4 Shea Jacqueline Elizabeth · CIK 0001771498 · Director · Chief Executive Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 127,060 F4 · kind: The transaction reported represents the withholding of shares by the issuer to satisfy the reporting person's tax withholding obligations in connection with the vesting and settlement of the restricted stock unit award reported in footnote (3) herein. Read SEC document |
| February 26, 2023 Filed Feb 28, 2023 22:44 UTC |
Shea Jacqueline ElizabethDirector · Chief Executive Officer
|
Exercise / conversionCommon Stock | 70,234 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001055726-23-000007 · wf-form4_167762425136925.xml · nonDerivative · entry 3 Shea Jacqueline Elizabeth · CIK 0001771498 · Director · Chief Executive Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 159,545 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F3 · price: Each restricted stock unit represents a contingent right to receive one share of common stock. On February 26, 2022, the reporting person was granted 210,700 restricted stock units, vesting as follows: 70,234 shares vested on February 26, 2023; 70,233 shares will vest on February 26, 2024; and 70,233 shares will vest on February 26, 2025. Vested restricted stock units can be settled in shares of common stock, cash or a combination of both. Read SEC document |
| February 26, 2023 Filed Feb 28, 2023 22:44 UTC |
Shea Jacqueline ElizabethDirector · Chief Executive Officer
|
Tax withholdingCommon Stock | 9,788 | $1.28 | $12,528.64 |
DisclosureSEC source: 0001055726-23-000007 · wf-form4_167762425136925.xml · nonDerivative · entry 2 Shea Jacqueline Elizabeth · CIK 0001771498 · Director · Chief Executive Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 89,311 F2 · kind: The transaction reported represents the withholding of shares by the issuer to satisfy the reporting person's tax withholding obligations in connection with the vesting and settlement of the restricted stock unit award reported in footnote (1) herein. Read SEC document |
| February 26, 2023 Filed Feb 28, 2023 22:44 UTC |
Shea Jacqueline ElizabethDirector · Chief Executive Officer
|
Exercise / conversionCommon Stock | 22,544 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001055726-23-000007 · wf-form4_167762425136925.xml · nonDerivative · entry 1 Shea Jacqueline Elizabeth · CIK 0001771498 · Director · Chief Executive Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 99,099 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · price: Each restricted stock unit represents a contingent right to receive one share of common stock. On February 26, 2021, the reporting person was granted 67,633 restricted stock units, vesting as follows: 22,545 shares vested on February 26, 2022; 22,544 shares vested on February 26, 2023; and 22,544 shares will vest on February 26, 2024. Vested restricted stock units can be settled in shares of common stock, cash or a combination of both. Read SEC document |
| February 26, 2023 Filed Feb 28, 2023 22:43 UTC |
Humeau LaurentChief Scientific Officer
|
Exercise / conversionRestricted Stock Unit · Derivative | 46,267 | $0.00 | $0.00 |
DisclosureSEC source: 0001055726-23-000006 · wf-form4_167762417016584.xml · derivative · entry 6 Humeau Laurent · CIK 0001770390 · Chief Scientific Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 92,533 Underlying: Common Stock · 46,267 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F3 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of common stock. On February 26, 2022, the reporting person was granted 138,800 restricted stock units, vesting as follows: 46,267 shares vested on February 26, 2023; 46,267 shares will vest on February 26, 2024; and 46,266 shares will vest on February 26, 2025. Vested restricted stock units can be settled in shares of common stock, cash or a combination of both. F3 · derivative.exercise_date: Each restricted stock unit represents a contingent right to receive one share of common stock. On February 26, 2022, the reporting person was granted 138,800 restricted stock units, vesting as follows: 46,267 shares vested on February 26, 2023; 46,267 shares will vest on February 26, 2024; and 46,266 shares will vest on February 26, 2025. Vested restricted stock units can be settled in shares of common stock, cash or a combination of both. F3 · derivative.expiration_date: Each restricted stock unit represents a contingent right to receive one share of common stock. On February 26, 2022, the reporting person was granted 138,800 restricted stock units, vesting as follows: 46,267 shares vested on February 26, 2023; 46,267 shares will vest on February 26, 2024; and 46,266 shares will vest on February 26, 2025. Vested restricted stock units can be settled in shares of common stock, cash or a combination of both. Read SEC document |
| February 26, 2023 Filed Feb 28, 2023 22:43 UTC |
Humeau LaurentChief Scientific Officer
|
Exercise / conversionRestricted Stock Unit · Derivative | 22,544 | $0.00 | $0.00 |
DisclosureSEC source: 0001055726-23-000006 · wf-form4_167762417016584.xml · derivative · entry 5 Humeau Laurent · CIK 0001770390 · Chief Scientific Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 22,544 Underlying: Common Stock · 22,544 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of common stock. On February 26, 2021, the reporting person was granted 67,633 restricted stock units, vesting as follows: 22,545 shares vested on February 26, 2022; 22,544 shares vested on February 26, 2023; and 22,544 shares will vest on February 26, 2024. Vested restricted stock units can be settled in shares of common stock, cash or a combination of both. F1 · derivative.exercise_date: Each restricted stock unit represents a contingent right to receive one share of common stock. On February 26, 2021, the reporting person was granted 67,633 restricted stock units, vesting as follows: 22,545 shares vested on February 26, 2022; 22,544 shares vested on February 26, 2023; and 22,544 shares will vest on February 26, 2024. Vested restricted stock units can be settled in shares of common stock, cash or a combination of both. F1 · derivative.expiration_date: Each restricted stock unit represents a contingent right to receive one share of common stock. On February 26, 2021, the reporting person was granted 67,633 restricted stock units, vesting as follows: 22,545 shares vested on February 26, 2022; 22,544 shares vested on February 26, 2023; and 22,544 shares will vest on February 26, 2024. Vested restricted stock units can be settled in shares of common stock, cash or a combination of both. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.